Veradermics, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company was founded in 2019 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Veradermics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Veradermics Inc market cap is $7.6B.
What is the 52-week high for Veradermics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Veradermics Inc 52 week high is $40.01 as of February 06, 2026.
What is the 52-week low for Veradermics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Veradermics Inc 52 week low is $32.00 as of February 06, 2026.
What is Veradermics Inc stock price today?
Veradermics Inc stock price today is $37.16.
What was Veradermics Inc stock price yesterday?
Veradermics Inc stock price yesterday was $37.75.
What is the Price-to-Book ratio of Veradermics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Veradermics Inc P/B ratio is -156.7756.
What is the 50-day moving average of Veradermics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Veradermics Inc 50-day moving average is $37.75.